All In Biotech

Free tool

FAERS Monitor: Dulera

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022518 or its brand name (Dulera, Formoterol Fumarate, Mometasone Furoate). Reports on generic versions are filed under their own applications.

Reports

16,226

Serious

4,892

30% of reports

Hospitalization

2,500

Death reported

443

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • product quality issue3,321
  • no adverse event3,122
  • drug dose omission2,135
  • dyspnoea1,794
  • poor quality device used1,556
  • device malfunction1,238
  • cough913
  • drug ineffective886
  • asthma858
  • product dose omission issue769
  • fatigue658
  • headache627
  • incorrect dose administered609
  • product use issue562
  • pneumonia510

Reports by year received

View as table
YearReports
20101
201112
2012512
20131,067
20141,447
20151,603
20161,892
20171,606
20181,400
20191,294
20201,209
2021951
2022828
2023446
2024510
2025486
2026962

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,933 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
poor quality device usedSignal1,556237.7225.7309,893
product quality issueSignal3,32132.531.599,411
device malfunctionSignal1,23823.222.025,934
no adverse eventSignal3,12222.722.064,209
drug dose omissionSignal2,13516.916.331,859
asthmaSignal8589.99.36,848
coughSignal9134.24.02,272
dyspnoeaSignal1,7944.13.94,335
product use issueSignal5623.93.61,208
incorrect dose administeredSignal6093.53.21,074
product dose omission issueSignal7693.43.21,313
pneumoniaSignal5102.01.9275
headache6271.31.244
fatigue6581.11.06
drug ineffective8860.90.818

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.